Works matching IS 0344-5704 AND VI 62 AND IP 6 AND DT 2008

Results: 24

Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELtrade mark), a multi-targeted kinase inhibitor.

Published in:

2008

By:

Luo FR;
Barrett YC;
Yang Z;
Camuso A;
McGlinchey K;
Wen ML;
Smykla R;
Fager K;
Wild R;
Palme H;
Galbraith S;
Blackwood-Chirchir A;
Lee FY

Publication type:

Journal Article

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.

Published in:

2008

By:

Thompson PA;
Gupta M;
Rosner GL;
Yu A;
Barrett J;
Bomgaars L;
Bernstein ML;
Blaney SM;
Mondick J;
Thompson, Patrick A;
Gupta, Manish;
Rosner, Gary L;
Yu, Alexander;
Barrett, Jeffrey;
Bomgaars, Lisa;
Bernstein, Mark L;
Blaney, Susan M;
Mondick, John

Publication type:

journal article

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 931, doi. 10.1007/s00280-008-0681-2

By:

François, Eric;
Berdah, Jean-François;
Chamorey, Emmanuel;
Lesbats, Gérard;
Teissier, Eric;
Codoul, Jean-François;
Badetti, Jean-Luc;
Hébert, Christophe;
Mari, Véronique

Publication type:

Article

Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 937, doi. 10.1007/s00280-008-0683-0

By:

Mauritz, Robert;
Peters, Godefridus J.;
Kathmann, Ietje;
Teshale, Habte;
Noordhuis, Paul;
Comijn, Elizabeth M.;
Pinedo, Herbert M.;
Jansen, Gerrit

Publication type:

Article

Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 949, doi. 10.1007/s00280-008-0684-z

By:

Zhigang Xie;
Pei Feng Choong;
Lai Fong Poon;
Jianbiao Zhou;
Jiaying Khng;
Jasinghe, Viraj Janakakumara;
Palaniyandi, Senthilnathan;
Chien-Shing Chen

Publication type:

Article

Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 959, doi. 10.1007/s00280-008-0685-y

By:

Nagai, Hidenari;
Miyaki, Daisuke;
Matsui, Teppei;
Kanayama, Masahiro;
Higami, Katsuya;
Momiyama, Kouichi;
Ikehara, Takashi;
Watanabe, Manabu;
Sumino, Yasukiyo;
Miki, Kazumasa

Publication type:

Article

BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 965, doi. 10.1007/s00280-008-0686-x

By:

Hyo Jin Kang;
Hee Jeong Kim;
Chi-Heum Cho;
Yanfen Hu;
Rong Li;
Insoo Bae

Publication type:

Article

Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 977, doi. 10.1007/s00280-008-0687-9

By:

Xing-Jie Liang;
Jun-Jie Yin;
Barbara Taylor;
Winkovitch, Stephen M.;
GarWeld, Susan H.;
Ding-Wu Shen;
Gottesman, Michael M.;
Aszalos, Adorjan

Publication type:

Article

Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 985, doi. 10.1007/s00280-008-0688-8

By:

Xianhua Cao;
Guang Jia;
Tao Zhang;
Ming Yang;
Bing Wang;
Wassenaar, Peter A.;
Hao Cheng;
Knopp, Michael V.;
Duxin Sun

Publication type:

Article

Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 995, doi. 10.1007/s00280-008-0689-7

By:

Callizot, Noelle;
Andriambeloson, Emile;
Glass, Jonathan;
Revel, Michel;
Ferro, Pamela;
Cirillo, Rocco;
Vitte, Pierre-Alain;
Dreano, Michel

Publication type:

Article

Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1009, doi. 10.1007/s00280-008-0690-1

By:

Se Hoon Park;
Eun Kyung Cho;
Yujin Kim;
Sun Young Kyung;
Chang Hyeok An;
Sang Pyo Lee;
Jeong Woong Park;
Sung Hwan Jeong;
Jae-Ik Lee;
Soo Jin Choi;
Jinny Park;
Dong Bok Shin;
Jae Hoon Lee

Publication type:

Article

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1015, doi. 10.1007/s00280-008-0691-0

By:

Min Huang;
Jing Jin;
Hua Sun;
Geng Tao Liu

Publication type:

Article

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1027, doi. 10.1007/s00280-008-0692-z

By:

Thompson, Patrick A.;
Gupta, Manish;
Rosner, Gary L.;
Yu, Alexander;
Barrett, JeVrey;
Bomgaars, Lisa;
Bernstein, Mark L.;
Blaney, Susan M.;
Mondick, John

Publication type:

Article

A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1103, doi. 10.1007/s00280-008-0693-y

By:

Nakajo, Akihiro;
Hokita, Shuichi;
Ishigami, Sumiya;
Miyazono, Futoshi;
Etoh, Tadaaki;
Hamanoue, Masahiro;
Maenohara, Shigeho;
Iwashita, Toshimitsu;
Komatsu, Hideaki;
Satoh, Kiyoharu;
Aridome, Kuniaki;
Morita, Satoshi;
Natsugoe, Shoji;
Takiuchi, Hiroya;
Nakano, Shyuji;
Maehara, Yoshihiko;
Sakamoto, Junichi;
Aikou, Takashi;
Taxol, Kyushu

Publication type:

Article

Topotecan distribution in an anephric infant with therapy resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1039, doi. 10.1007/s00280-008-0694-x

By:

Lugtenberg, Rieneke T.;
Cransberg, Karlien;
Loos, Walter J.;
Wagner, Anja;
Alders, Marielle;
van den Heuvel-Eibrink, Marry M.

Publication type:

Article

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1045, doi. 10.1007/s00280-008-0695-9

By:

O'Reilly, Terence;
Wartmann, Markus;
Brueggen, Joseph;
Allegrini, Peter R.;
Floersheimer, Andreas;
Maira, Michel;
McSheehy, Paul M. J.

Publication type:

Article

Is oncogenesis a normal cellular defense mechanism?

Published in:

2008

By:

Sorscher, Steven;
Hill, Aubrey E.;
Sorscher, Eric J.

Publication type:

Letter

Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1055, doi. 10.1007/s00280-008-0697-7

By:

San-Hua Wei;
Ke Dong;
Fang Lin;
Xi Wang;
Bin Li;
Jian-jun Shen;
Qing Zhang;
Rui Wang;
Hui-Zhong Zhang

Publication type:

Article

Tumor resensitization to erlotinib following brief substitution of cetuximab.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1111, doi. 10.1007/s00280-008-0698-6

By:

Epstein, R. J.;
Leung, T. W.

Publication type:

Article

Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL™), a multi-targeted kinase inhibitor.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1065, doi. 10.1007/s00280-008-0699-5

By:

Feng Luo;
Yu Chen Barrett;
Zheng Yang;
Camuso, Amy;
McGlinchey, Kelly;
Mei-Li Wen;
Smykla, Richard;
Fager, Krista;
Wild, Robert;
Palme, Holly;
Galbraith, Susan;
Blackwood-Chirchir, Anne;
Lee, Francis Y.

Publication type:

Article

Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1075, doi. 10.1007/s00280-008-0700-3

By:

Font, Albert;
Salazar, Ramon;
Maurel, Joan;
Taron, Miquel;
Ramirez, Jose Luis;
Tabernero, Josep;
Gallego, Rosa;
Casado, Esther;
Manzano, Jose Luis;
Carcereny, Enric;
Guix, Marta;
Fernández-Llamazares, Jaume;
Rosell, Rafael

Publication type:

Article

Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1085, doi. 10.1007/s00280-008-0709-7

By:

Ruiz, M.;
Salvador, J.;
Bayo, J.;
Lomas, M.;
Moreno, A.;
Valero, M.;
Bernabé, R.;
Vicente, D.;
Jiménez, J.;
Lopez-Ladrón, A.

Publication type:

Article

Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1091, doi. 10.1007/s00280-008-0771-1

By:

Brown, Alan P.;
Courtney, Cynthia L.;
Criswell, Kay A.;
Holliman, Christopher L.;
Evering, Winston;
Jessen, Bart A.

Publication type:

Article

Professor Lloyd R. Kelland: man of science.

Published in:

2008

By:

Newell, Herbie;
McKeage, Mark;
Stanway, Clive

Publication type:

Obituary